The Hub for Disease-Specific Clinical Information
Advertisement
Advertisement

Andrew D. Seidman, MD, and Aditya Bardia, MD, MPH, on Use of Sacituzumab Govitecan in Metastatic Breast Cancer

Posted: Monday, June 18, 2018

Andrew D. Seidman, MD, of Memorial Sloan Kettering Cancer Center, and Aditya Bardia, MD, MPH, of Massachusetts General Hospital, discuss the efficacy of sacituzumab govitecan for treatment-refractory hormone receptor–positive/HER2-negative metastatic breast cancer.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.